ORAPRED ODT (PREDNISOLONE SODIUM PHOSPHATE) — FDA Approval NDA021959 (ADVANZ PHARMA)
ORAPRED ODT (PREDNISOLONE SODIUM PHOSPHATE) — FDA Approval NDA021959 (ADVANZ PHARMA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ORAPRED ODT; Active ingredients: PREDNISOLONE SODIUM PHOSPHATE; Application number: NDA021959.
| Brand name | ORAPRED ODT |
|---|---|
| Active ingredients | PREDNISOLONE SODIUM PHOSPHATE |
| Application number | NDA021959 |
| Sponsor | ADVANZ PHARMA |
| Dosage form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 3 |
| First approval date | 20060601 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →